These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 33493185)

  • 1. T cell response to SARS-CoV-2 infection in humans: A systematic review.
    Shrotri M; van Schalkwyk MCI; Post N; Eddy D; Huntley C; Leeman D; Rigby S; Williams SV; Bermingham WH; Kellam P; Maher J; Shields AM; Amirthalingam G; Peacock SJ; Ismail SA
    PLoS One; 2021; 16(1):e0245532. PubMed ID: 33493185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody response to SARS-CoV-2 infection in humans: A systematic review.
    Post N; Eddy D; Huntley C; van Schalkwyk MCI; Shrotri M; Leeman D; Rigby S; Williams SV; Bermingham WH; Kellam P; Maher J; Shields AM; Amirthalingam G; Peacock SJ; Ismail SA
    PLoS One; 2020; 15(12):e0244126. PubMed ID: 33382764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The T cell immune response against SARS-CoV-2.
    Moss P
    Nat Immunol; 2022 Feb; 23(2):186-193. PubMed ID: 35105982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convalescent Memory T Cell Immunity in Individuals with Mild or Asymptomatic SARS-CoV-2 Infection May Result from an Evolutionarily Adapted Immune Response to Coronavirus and the 'Common Cold'.
    Stefano GB; Kream RM
    Med Sci Monit; 2020 Nov; 26():e929789. PubMed ID: 33239605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2-associated lymphopenia: possible mechanisms and the role of CD147.
    Shouman S; El-Kholy N; Hussien AE; El-Derby AM; Magdy S; Abou-Shanab AM; Elmehrath AO; Abdelwaly A; Helal M; El-Badri N
    Cell Commun Signal; 2024 Jul; 22(1):349. PubMed ID: 38965547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques.
    Hasenkrug KJ; Feldmann F; Myers L; Santiago ML; Guo K; Barrett BS; Mickens KL; Carmody A; Okumura A; Rao D; Collins MM; Messer RJ; Lovaglio J; Shaia C; Rosenke R; van Doremalen N; Clancy C; Saturday G; Hanley P; Smith BJ; Meade-White K; Shupert WL; Hawman DW; Feldmann H
    mBio; 2021 Aug; 12(4):e0150321. PubMed ID: 34311582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The known unknowns of T cell immunity to COVID-19.
    Karlsson AC; Humbert M; Buggert M
    Sci Immunol; 2020 Nov; 5(53):. PubMed ID: 33208380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct Mitochondria-Mediated T-Cell Apoptosis Responses in Children and Adults With Coronavirus Disease 2019.
    Yang Y; Kuang L; Li L; Wu Y; Zhong B; Huang X
    J Infect Dis; 2021 Oct; 224(8):1333-1344. PubMed ID: 34374752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypes and Functions of SARS-CoV-2-Reactive T Cells.
    Jung MK; Shin EC
    Mol Cells; 2021 Jun; 44(6):401-407. PubMed ID: 34120892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-existing T cell-mediated cross-reactivity to SARS-CoV-2 cannot solely be explained by prior exposure to endemic human coronaviruses.
    Tan CCS; Owen CJ; Tham CYL; Bertoletti A; van Dorp L; Balloux F
    Infect Genet Evol; 2021 Nov; 95():105075. PubMed ID: 34509646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deconvoluting the T Cell Response to SARS-CoV-2: Specificity Versus Chance and Cognate Cross-Reactivity.
    Lehmann AA; Kirchenbaum GA; Zhang T; Reche PA; Lehmann PV
    Front Immunol; 2021; 12():635942. PubMed ID: 34127926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
    Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR
    Elife; 2021 Oct; 10():. PubMed ID: 34636722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2-specific B- and T-cell immunity in a population-based study of young Swedish adults.
    Björkander S; Du L; Zuo F; Ekström S; Wang Y; Wan H; Sherina N; Schoutens L; Andréll J; Andersson N; Georgelis A; Bergström A; Marcotte H; Kull I; Hammarström L; Melén E; Pan-Hammarström Q;
    J Allergy Clin Immunol; 2022 Jan; 149(1):65-75.e8. PubMed ID: 34695490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses.
    Goletti D; Petrone L; Manissero D; Bertoletti A; Rao S; Ndunda N; Sette A; Nikolayevskyy V
    Clin Microbiol Infect; 2021 Dec; 27(12):1784-1789. PubMed ID: 34256141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell responses and therapies against SARS-CoV-2 infection.
    Toor SM; Saleh R; Sasidharan Nair V; Taha RZ; Elkord E
    Immunology; 2021 Jan; 162(1):30-43. PubMed ID: 32935333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers.
    Jackson-Thompson BM; Goguet E; Laing ED; Olsen CH; Pollett S; Hollis-Perry KM; Maiolatesi SE; Illinik L; Ramsey KF; Reyes AE; Alcorta Y; Wong MA; Davies J; Ortega O; Parmelee E; Lindrose AR; Moser M; Graydon E; Letizia AG; Duplessis CA; Ganesan A; Pratt KP; Malloy AM; Scott DW; Anderson SK; Snow AL; Dalgard CL; Powers JH; Tribble D; Burgess TH; Broder CC; Mitre E
    BMC Infect Dis; 2021 Jun; 21(1):544. PubMed ID: 34107889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Kang CK; Kim M; Lee S; Kim G; Choe PG; Park WB; Kim NJ; Lee CH; Kim IS; Jung K; Lee DS; Shin HM; Kim HR; Oh MD
    J Infect Dis; 2021 Jul; 224(1):39-48. PubMed ID: 33755725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses.
    Ogbe A; Kronsteiner B; Skelly DT; Pace M; Brown A; Adland E; Adair K; Akhter HD; Ali M; Ali SE; Angyal A; Ansari MA; Arancibia-Cárcamo CV; Brown H; Chinnakannan S; Conlon C; de Lara C; de Silva T; Dold C; Dong T; Donnison T; Eyre D; Flaxman A; Fletcher H; Gardner J; Grist JT; Hackstein CP; Jaruthamsophon K; Jeffery K; Lambe T; Lee L; Li W; Lim N; Matthews PC; Mentzer AJ; Moore SC; Naisbitt DJ; Ogese M; Ogg G; Openshaw P; Pirmohamed M; Pollard AJ; Ramamurthy N; Rongkard P; Rowland-Jones S; Sampson O; Screaton G; Sette A; Stafford L; Thompson C; Thomson PJ; Thwaites R; Vieira V; Weiskopf D; Zacharopoulou P; ; ; Turtle L; Klenerman P; Goulder P; Frater J; Barnes E; Dunachie S
    Nat Commun; 2021 Apr; 12(1):2055. PubMed ID: 33824342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.
    Nelde A; Bilich T; Heitmann JS; Maringer Y; Salih HR; Roerden M; Lübke M; Bauer J; Rieth J; Wacker M; Peter A; Hörber S; Traenkle B; Kaiser PD; Rothbauer U; Becker M; Junker D; Krause G; Strengert M; Schneiderhan-Marra N; Templin MF; Joos TO; Kowalewski DJ; Stos-Zweifel V; Fehr M; Rabsteyn A; Mirakaj V; Karbach J; Jäger E; Graf M; Gruber LC; Rachfalski D; Preuß B; Hagelstein I; Märklin M; Bakchoul T; Gouttefangeas C; Kohlbacher O; Klein R; Stevanović S; Rammensee HG; Walz JS
    Nat Immunol; 2021 Jan; 22(1):74-85. PubMed ID: 32999467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.